Immuron (IMRN) Assets Average (2016 - 2025)
Immuron (IMRN) posted quarterly Assets Average of $3.3 million for Q3 2025, down 36.67% year-over-year from $5.2 million in Q3 2024, and down 54.39% quarter-over-quarter from $7.2 million in Q2 2025.
Immuron (IMRN) Assets Average (2016 - 2025) Analysis & Trends
Immuron's Assets Average history runs 10 years deep, the most recent figure standing at $3.3 million for Q3 2025.
- In Q3 2025, Assets Average fell 36.67% year-over-year to $3.3 million; the TTM figure through Sep 2025 stood at $3.3 million (down 36.67% YoY), while the FY2025 annual figure was $3.3 million, down 35.61% from the prior year.
- Assets Average for Q3 2025 stood at $3.3 million, down from $7.2 million in the prior quarter.
- The five-year high for Assets Average was $17.5 million in Q3 2022, with the low at $3.3 million in Q3 2025.
- The 5-year median for Assets Average is $7.3 million (2023), against an average of $8.6 million.
- The sharpest annual moves came in 2022 and 2023: Assets Average jumped 59.94% in 2022, then sank 56.74% in 2023.
- Immuron's Assets Average stood at $10.5 million in 2021, then surged by 59.94% to $16.8 million in 2022, then tumbled by 56.74% to $7.3 million in 2023, then slumped by 44.2% to $4.1 million in 2024, then declined by 18.8% to $3.3 million in 2025.
- Business Quant data shows IMRN's Assets Average at $3.3 million in Q3 2025, $7.2 million in Q2 2025, and $4.1 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 3.29 Mn |
| Jun 30, 2025 | 7.22 Mn |
| Dec 31, 2024 | 4.06 Mn |
| Sep 9, 2024 | 5.20 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Dec 31, 2023 | 7.27 Mn |
| Jun 30, 2023 | 8.28 Mn |
| Dec 31, 2022 | 16.81 Mn |
| Aug 31, 2022 | 17.54 Mn |
| Jun 30, 2022 | 8.99 Mn |
| Dec 31, 2021 | 10.51 Mn |
| Jun 30, 2020 | 2.06 Mn |
| Dec 31, 2019 | 3.03 Mn |
| Jun 30, 2019 | 6.85 Mn |
| Jun 30, 2018 | 5.90 Mn |
| Jun 30, 2017 | 6.44 Mn |
| Dec 31, 2016 | 6.62 Mn |